Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Catechol‐O‐methyltransferase Inhibitors Versus Active Comparators for Levodopa‐induced Complications in Parkinson's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433578/all/Antidepressants_for_anorexia_nervosa_Edited__no_change_to_conclusions_. Accessed 24 April 2024.
Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433578/all/Antidepressants_for_anorexia_nervosa_Edited__no_change_to_conclusions_. Accessed April 24, 2024.
Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433578/all/Antidepressants_for_anorexia_nervosa_Edited__no_change_to_conclusions_
Catechol‐O‐methyltransferase Inhibitors Versus Active Comparators for Levodopa‐induced Complications in Parkinson's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433578/all/Antidepressants_for_anorexia_nervosa_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease
ID - 433578
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433578/all/Antidepressants_for_anorexia_nervosa_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -